Imatinib Completed Phase 1 Trials for Glioblastomas / Gliosarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00613132Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
NCT00613054Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma